FDA: ANDA Submissions—Amendments to ANDAs Under GDFUA [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2018-08-09 10:52 (1167 d 07:23 ago) – Posting: # 19161
Views: 1,740

Dear all,

a new Guidance for Industry

ANDA Submissions—Amendments to Abbreviated New Drug Applications Under GDUFA

was published in the Federal Register on July 5th.
See esp. APPENDIX A: MAJOR DEFICIENCIES, B. Bioequivalence Deficiencies.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,742 posts in 4,546 threads, 1,543 registered users;
online 10 (0 registered, 10 guests [including 6 identified bots]).
Forum time: Tuesday 18:15 CEST (Europe/Vienna)

Sometimes the key to an answer is found
in the way you formulate the question.    David Brin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz